Covadonga M. Diaz-Caneja, PhD, is affiliated with the Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM) and the Department of Child and Adolescent Psychiatry at Hospital General Universitario Gregorio Marañón and Universidad Complutense in Madrid, Spain. Their research, published between 2017 and 2023, focuses on neurodevelopmental and psychotic disorders, including schizophrenia and schizoaffective disorders. Diaz-Caneja has contributed to studies on neighborhood vulnerability in first-episode psychosis, premorbid predictors of early versus adult onset psychosis, and the impact of comorbid autism spectrum disorders on antipsychotic treatment outcomes in early-onset psychosis. Frequent collaborators include Celso Arango and the AGES-CM Group.
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
